← Research library

Cerebrolysin

Neurological · By Preptide Pro editorial team · Last updated

Cerebrolysin is a neurological peptide, and it is not FDA-approved. A mixture of peptides from purified pig brain protein. It is used in some countries for stroke and dementia and is not approved in the US.

Not FDA-approved

Chemistry (PubChem)

No matching PubChem compound record was found under this name.

Is Cerebrolysin FDA-approved?

Not FDA-approved. No matching NDA or BLA was found in openFDA (Drugs@FDA).

How much research is there on Cerebrolysin?

PubMed lists 676 records for “cerebrolysin”, of which 90 are tagged as human clinical trials.

Most recent PubMed records
Recent studyJournalDate
Post-endovascular thrombectomy perfusion imaging (CT and MR) as a prognostic biomarker and patient-selection tool for adjuvant therapy: A systematic review, meta-analysis, and clinical threshold framework.J Stroke Cerebrovasc Dis2026 Oct
An Adaptive, Time-Informed, Phenotype-Guided Pharmacological Framework for Severe Traumatic Brain Injury : A Hypothesis-Driven Narrative Review.J Korean Neurosurg Soc2026 Sep 1
Very Early Short-Course Cerebrolysin After Tenecteplase and Mechanical Thrombectomy: A Case Report.Case Rep Neurol Med2026
Impact of N-PEP-12 Supplementation on Attentional Performance and Mental Wellbeing in Healthy Adults with Subjective Cognitive Complaints: A Randomized, Placebo-Controlled Trial.Nutrients2026 Aug 21
Adjunctive Cerebrolysin therapy following mechanical thrombectomy for tandem right internal carotid artery and middle cerebral artery occlusion with residual post-procedural perfusion deficit: a case report.J Med Life2026 Aug

Sources

This is general research information, not medical advice. Check with a clinician before using any compound.

Preptide Pro is a tracking tool, not medical advice. Talk to a clinician about any treatment.